SLB Technology highlights new FDA Drug Master File for GDT exosomes
SLB Technology said it highlighted a new FDA Drug Master File covering GDT cell-derived exosomes.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.